Evotec buys majority stake in RSIPL for €2.8 million
06 August 2009
Sita Shah
Please Login to read the full article.
06 August 2009
Sita Shah
sita.shah@informa.com
Evotec is to pay €2.8 million in cash to buy a 70% stake in India's Research Support International (RSIPL) to strengthen its drug discovery operations.
The deal will expand Evotec's capacity in a low-cost area as it seeks to optimise its preclinical pipeline and prioritise the most promising...
Please Login to read the full article.
RELATED CONTENT
NEWS
- €4 million Boehringer milestone seals positive week for deflated Evotec
- Roche and Evotec end depression alliance as Phase II trial proves 'too difficult'
- Stockwatch: A slimmer AstraZeneca starts to look tasty
- Weaker private equity in India for 2012, portfolios turning 'a la carte'
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
